CAPTRUST Financial Advisors
ARCT icon

CAPTRUST Financial Advisors’s Arcturus Therapeutics ARCT Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-36
Closed -$1K – 2174
2022
Q2 		$1K Hold
36
– – ﹤0.01% 4622
2022
Q1 		$1K Hold
36
– – ﹤0.01% 4648
2021
Q4 		$1K Hold
36
– – ﹤0.01% 4530
2021
Q3 		$2K Sell
36
-16
-31% -$717 ﹤0.01% 4230
2021
Q2 		$2K Buy
52
+33
+174% +$1.12K ﹤0.01% 4141
2021
Q1 		$1K Buy
+19
New +$1.13K ﹤0.01% 4162

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

CAPTRUST Financial Advisors's ARCT Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Arcturus Therapeutics (ARCT) in Q3 2022, closing a stake of 36 shares — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in ARCT in Q1 2021 and held it in 6 quarters. The position peaked at $2K in Q3 2021. 116 funds tracked by Wall St. Rank hold ARCT as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Arcturus Therapeutics position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 36 Arcturus Therapeutics shares in Q3 2022, an estimated $1K.
  • CAPTRUST Financial Advisors first reported a position in Arcturus Therapeutics in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's Arcturus Therapeutics position peaked at $2K in Q3 2021.
  • 116 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.